PositiveID Corporation, a life sciences and technology company, develops and sells molecular diagnostic systems for bio-threat detection and medical testing in the United States and internationally. It operates through three segments: Molecular Diagnostics, Medical Devices, and Mobile Labs. The company develops microfluidic systems for the automated preparation and performance of biological assays to detect biological threats and analyze biological samples at the point of need. It has a portfolio of intellectual property related to sample preparation and rapid medical testing applications. The company's microfluidic bio-agent autonomous networked detector (M-BAND) technology is a bio-aerosol monitor with integrated systems for sample collection, processing, and detection modules. Its M-BAND technology analyzes air samples for the detection of pathogenic bacteria, viruses, and toxins for up to 30 days. The company's FireflyDX is an automated pathogen detection system for rapid diagnostics for clinical and point-of-need applications. Its FireflyDX system detects and identifies common pathogens and diseases, such as E. coli, methicillin-resistant staphylococcus aureus, methicillin-susceptible staphylococcus aureus, clostridium difficile, Zika virus, Ebola virus, influenza, and others. In addition, PositiveID Corporation markets Caregiver, a non-contact clinical thermometer that measures forehead temperature in adults, children, and infants for hospitals, physicians' offices, medical clinics, nursing homes and other long-term care institutions, and acute care hospitals; and manufactures and sells specialty technology vehicles for mobile laboratory, command and communications applications, and mobile cellular systems. The company was formerly known as VeriChip Corporation and changed its name to PositiveID Corporation in November 2009. PositiveID Corporation was founded in 2001 and is headquartered in Delray Beach, Florida.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PSID
Previous Symbol
CUSIPN/A
Phone561-805-8008
Debt
Debt-to-Equity RatioN/A
Current Ratio0.01
Quick Ratio0.01
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$5.36 million
Price / Sales0.00
Cash FlowN/A
Price / CashN/A
Book Value($27.01) per share
Price / Book0.00
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-8,560,000.00
Net Margins-166.73%
Return on EquityN/A
Return on Assets-304.11%
Miscellaneous
Employees9
Outstanding Shares9,390,000
Market Cap$0.00
OptionableNot Optionable
PositiveID (OTCMKTS:PSID) Frequently Asked Questions
What is PositiveID's stock symbol?
PositiveID trades on the OTCMKTS under the ticker symbol "PSID."
How were PositiveID's earnings last quarter?
PositiveID Corp (OTCMKTS:PSID) posted its earnings results on Wednesday, November, 19th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.01) by $0.01. The business had revenue of $0.33 million for the quarter, compared to analyst estimates of $0.40 million. View PositiveID's Earnings History.
When is PositiveID's next earnings date?
Has PositiveID been receiving favorable news coverage?
Headlines about PSID stock have trended somewhat positive recently, InfoTrie reports. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. PositiveID earned a daily sentiment score of 0.7 on InfoTrie's scale. They also gave media stories about the company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the next several days.
Who are some of PositiveID's key competitors?
Some companies that are related to PositiveID include Illumina (ILMN), Agilent Technologies (A), Waters (WAT), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories, Inc. Class B (BIO.B), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Fluidigm (FLDM) and Eyepoint Pharmaceuticals (EYPT).
Who are PositiveID's key executives?
PositiveID's management team includes the folowing people:
- Mr. William J. Caragol, Chairman, CEO & Acting CFO (Age 51)
- Mr. Gary J. O'Hara, Chief Technology Officer (Age 68)
- Ms. Allison F. Tomek, Sr. VP of Corp. Devel. & Sec.
- Dr. Kimothy Smith, Chief Technology Advisor & Member of Advisory Board
How do I buy shares of PositiveID?
Shares of PSID can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is PositiveID's stock price today?
One share of PSID stock can currently be purchased for approximately $0.0002.
What is PositiveID's official website?
How can I contact PositiveID?
PositiveID's mailing address is 1690 SOUTH CONGRESS AVENUE SUITE 201, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-805-8008.
MarketBeat Community Rating for PositiveID (OTCMKTS PSID)
MarketBeat's community ratings are surveys of what our community members think about PositiveID and other stocks. Vote "Outperform" if you believe PSID will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PSID will underperform the S&P 500 over the long term. You may vote once every thirty days.
